FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories Sulfamethoxazole and Trimethoprim Recall

Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 100 Tablets un…

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories · La Vergne, TN

Risk level
Class II
Reported by FDA
Sep 17, 2025
Recall ID
D-0624-2025
Check your lot numberHow we source this data

Summary

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalled Sulfamethoxazole and Trimethoprim starting Sep 2, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0624-2025 on Sep 17, 2025. Reason: Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets. Status: Ongoing.

Why it was recalled

Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

Product description

Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 100 Tablets unit dose blister packs (10x10) per carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-2725-61

Lot numbers, UPCs & expiration codes

Lot # N02309, Exp 03/31/2027

Where it was sold

USA Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0624-2025
Classification
Class II
Status
Ongoing
Recall initiated
Sep 2, 2025
FDA report date
Sep 17, 2025
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Original FDA data

Every field from FDA enforcement report D-0624-2025, exactly as published.

Show all FDA fields
City
La Vergne
State
TN
Status
Ongoing
Country
United States
Event ID
97523
Address
341 Mason Rd
Code information
Lot # N02309, Exp 03/31/2027
Postal code
37086-3606
Report date
Sep 17, 2025
Product type
Drugs
Recall number
D-0624-2025
Classification
Class II
Recalling firm
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Reason for recall
Presence of a Foreign Substance: A specific lot of auxiliary polyester coil, used in product packaging by manufacturer (Amneal Pharmaceuticals LLC) was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sulfamethoxazole and Trimethoprim, USP, 800 mg/160 mg, Double Strength, 100 Tablets unit dose blister packs (10x10) per carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-2725-61
Distribution pattern
USA Nationwide.
Recall initiation date
Sep 2, 2025
Initial firm notification
Letter
Center classification date
Sep 10, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0624-2025, published Sep 17, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls